Fractional-to-Full-Time CMO — Solid Tumor Oncology

Green Life Science; United States; Hybrid; USD 150,000 - 210,000; Full time

Benefits offered by this job

Significant equity stake

Leadership role at growth stage

Path to full-time CMO

Job summary

Green Life Sciences seeks a Chief Medical Officer to guide the clinical strategy as the oncology asset moves from Phase II to Phase III. The role begins on a fractional basis (about 10 hours/week) with flexibility for investor meetings and aims to transition to full-time upon securing funding.

You will lead fundraising discussions, shape partnerships with big pharma, and direct the clinical development plan while representing the programme to investors and the oncology community.

Qualifications

• Senior medical or clinical development leadership experience in pharma/biotech.
• Strong background in solid tumour oncology.
• Established relationships across the pharmaceutical industry.
• Experience with due diligence, licensing, partnerships is desirable.

Responsibilities

• Lead clinical strategy through Phase II to Phase III transition.
• Represent clinical programme in fundraising and investor meetings.
• Build strategic partnerships with larger pharmaceutical companies.
• Communicate programme progress to investors, partners and oncology community.

Skills

Senior medical leadership

Solid tumour oncology

Pharma/biotech relationships

Due diligence & licensing

Job description

Green Life Sciences seeks a Chief Medical Officer to guide the clinical strategy as the oncology asset moves from Phase II to Phase III. The role begins on a fractional basis (about 10 hours/week) with flexibility for investor meetings and aims to transition to full-time upon securing funding.

You will lead fundraising discussions, shape partnerships with big pharma, and direct the clinical development plan while representing the programme to investors and the oncology community.